News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,084 Results
Type
Article (39700)
Company Profile (247)
Press Release (659137)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204169)
Career Advice (2007)
Deals (35418)
Drug Delivery (95)
Drug Development (81046)
Employer Resources (172)
FDA (16183)
Job Trends (14859)
News (345192)
Policy (32538)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49437)
ALS (88)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (126)
Approvals (16185)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (281)
Cancer (2275)
Cardiovascular disease (175)
Career advice (1676)
Career pathing (30)
CAR-T (152)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66011)
Collaboration (837)
Company closure (1)
Compensation (548)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (245)
Cystic fibrosis (100)
Data (2228)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (272)
Diagnostics (6372)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86698)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112460)
Executive appointments (731)
FDA (17467)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (306)
GLP-1 (711)
Government (4417)
Grass and pollen (4)
Guidances (81)
Healthcare (18816)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16511)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7909)
Liver cancer (76)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (307)
MASH (68)
Medical device (13379)
Medtech (13384)
Mergers & acquisitions (19460)
Metabolic disorders (691)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1915)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (367)
Opinion (204)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (86)
Parkinson's disease (148)
Partnered (21)
Patents (237)
Patient recruitment (112)
Peanut (46)
People (57318)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20567)
Phase II (29069)
Phase III (21655)
Pipeline (1227)
Policy (140)
Postmarket research (2563)
Preclinical (8744)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22293)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (86)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (29)
Vaccines (691)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (180)
Last 7 days (820)
Last 30 days (2709)
Last 365 days (32739)
2025 (10982)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37852)
Australia (6186)
California (6188)
Canada (2032)
China (526)
Colorado (266)
Connecticut (275)
Delaware (150)
Europe (81289)
Florida (916)
Georgia (207)
Idaho (57)
Illinois (540)
India (25)
Indiana (312)
Iowa (11)
Japan (165)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4608)
Michigan (220)
Minnesota (394)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1742)
New Mexico (28)
New York (1762)
North Carolina (975)
North Dakota (8)
Northern California (2708)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1387)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2328)
Tennessee (102)
Texas (921)
United States (23311)
Utah (183)
Virginia (147)
Washington D.C. (63)
Washington State (553)
West Virginia (3)
Wisconsin (55)
699,084 Results for "orphomed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
OrphoMed, Inc. Announces Positive Phase 2 Results for ORP-101 100 mg Once-Daily Dose in IBS-D Patients
OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, today announced positive results from the recent Phase 2 study of ORP-101 for treatment of irritable bowel syndrome with diarrhea (IBS-D).
January 4, 2022
·
6 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
RxSight, Inc. to Present at the Bank of America Healthcare Conference
May 1, 2025
·
1 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
UL Solutions Inc. Reports Strong First Quarter 2025 Results
May 6, 2025
·
20 min read
Press Releases
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 29, 2025
·
1 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Penumbra, Inc. Reports First Quarter 2025 Financial Results
April 23, 2025
·
15 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
April 21, 2025
·
4 min read
1 of 69,909
Next
